UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000011778
Receipt No. R000013769
Official scientific title of the study Therapeutic outcome of unoprostone and nipradilol in patients with normal tension glaucoma.
Date of disclosure of the study information 2013/09/17
Last modified on 2017/06/03 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Therapeutic outcome of unoprostone and nipradilol in patients with normal tension glaucoma.
Title of the study (Brief title) Therapeutic outcome of unoprostone and nipradilol
Region
Japan

Condition
Condition normal tension glaucoma
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 the ocular hypotensive effect
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes intraocular pressure
Key secondary outcomes The incidence rate of side effect

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Cluster
Blinding Open -but assessor(s) are blinded
Control Active
Stratification YES
Dynamic allocation YES
Institution consideration Institution is considered as a block.
Blocking YES
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 drug intervention
Interventions/Control_2 drug intervention
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria normal tension glaucoma
Key exclusion criteria neuro-ophthalmic disease and chorioretinopathy patients
Target sample size 50

Research contact person
Name of lead principal investigator Takayuki Kanda
Organization National Defense Medical College
Division name Department of Ophthalmology
Address 3-2, Namiki, Tokorozawa, Saitama
TEL 04-2995-1683
Email kankan@ndmc.ac.jp

Public contact
Name of contact person Takayuki Kanda
Organization National Defense Medical College
Division name Department of Ophthalmology
Address 3-2, Namiki, Tokorozawa, Saitama
TEL 04-2995-1683
Homepage URL
Email kankan@ndmc.ac.jp

Sponsor
Institute Department of Ophthalmology, National Defense Medical College
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 09 Month 17 Day

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2011 Year 07 Month 01 Day
Anticipated trial start date
2011 Year 07 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2013 Year 09 Month 17 Day
Last modified on
2017 Year 06 Month 03 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000013769